Likewise, immunotherapy approaches were shown to induce the recognition and destruction of tumor vasculature (Ugel et al., 2015b), which was also demonstrated in a study applying CAR-T cells model targeting VEGFR2 (Chinnasamy et al., 2010; Kanagawa et al., 2013). This evidence concerns the gene KDR and neoplasm.